1.
Emerg Infect Dis
; 29(3): 656-658, 2023 03.
Artículo
en Inglés
| MEDLINE
| ID: mdl-36732061
RESUMEN
Smallpox vaccination may confer cross-protection to mpox. We evaluated vaccinia virus antibodies in 162 persons ≥50 years of age in Spain; 68.5% had detectable antibodies. Highest coverage (78%) was among persons 71-80 years of age. Low antibody levels in 31.5% of this population indicates that addressing their vaccination should be a priority.